This gentle, science-backed formula is designed to support digestion and reduce common discomforts like bloating, nausea, and stomach upset
Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI
If you have moderate-to-severe obstructive sleep apnea confirmed by sleep study plus BMI 30, Zepbound via the OSA indication is still approved through Aetna's standard PA process
Is this just another case of media hysteria, or is there really something to be concerned about